$RSPI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in RespireRx Pharmaceuticals Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in RespireRx Pharmaceuticals Inc.. Get notifications about new insider transactions in RespireRx Pharmaceuticals Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 20 2016 | RSPI | RespireRx Pharmace ... | Margolis Jeff Eliot | VP, Treasurer & Sec ... | Buy | J | 0.00 | 5,000,000 | 0 | 5,000,000 | 0 to 5 M |
Jun 20 2016 | RSPI | RespireRx Pharmace ... | Margolis Jeff Eliot | VP, Treasurer & Sec ... | Sell | J | 0.00 | 5,000,000 | 0 | 10,134,944 | 15.1 M to 10.1 M (-33.04 %) |
Jun 20 2016 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | J | 0.02 | 24,000,000 | 544,800 | 0 | |
Jun 20 2016 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | J | 0.02 | 10,000,000 | 197,000 | 0 | |
Jun 20 2016 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | J | 0.03 | 15,000,000 | 375,000 | 0 | |
Apr 04 2016 | RSPI | RespireRx Pharmace ... | Purcell Richard David Jr. | SVP - Research & De ... | Option Exercise | A | 0.02 | 20,000,000 | 454,000 | 20,000,000 | |
Apr 04 2016 | RSPI | RespireRx Pharmace ... | MacFarlane Katie | Director | Option Exercise | A | 0.02 | 10,000,000 | 227,000 | 10,000,000 | |
Apr 04 2016 | RSPI | RespireRx Pharmace ... | SAPIRSTEIN JAMES | Director | Option Exercise | A | 0.02 | 10,000,000 | 227,000 | 10,000,000 | |
Apr 04 2016 | RSPI | RespireRx Pharmace ... | WEINGARTEN ROBERT N | VP & CFO | Option Exercise | A | 0.02 | 24,000,000 | 544,800 | 24,000,000 | |
Apr 04 2016 | RSPI | RespireRx Pharmace ... | Margolis Jeff Eliot | VP, Treasurer & Sec ... | Option Exercise | A | 0.02 | 24,000,000 | 544,800 | 24,000,000 | |
Apr 04 2016 | RSPI | RespireRx Pharmace ... | Margolis Jeff Eliot | VP, Treasurer & Sec ... | Option Exercise | J | 0.02 | 939,729 | 19,734 | 1,574,726 | |
Apr 04 2016 | RSPI | RespireRx Pharmace ... | Margolis Jeff Eliot | VP, Treasurer & Sec ... | Option Exercise | J | 0.02 | 309,975 | 6,509 | 634,997 | |
Apr 04 2016 | RSPI | RespireRx Pharmace ... | Margolis Jeff Eliot | VP, Treasurer & Sec ... | Option Exercise | X | 0.04 | 507,374 | 17,758 | 0 | |
Apr 04 2016 | RSPI | RespireRx Pharmace ... | Margolis Jeff Eliot | VP, Treasurer & Sec ... | Option Exercise | J | 0.02 | 325,022 | 6,825 | 325,022 | |
Apr 04 2016 | RSPI | RespireRx Pharmace ... | Margolis Jeff Eliot | VP, Treasurer & Sec ... | Sell | S | 0.00 | 483,872 | 0 | 15,134,944 | 15.6 M to 15.1 M (-3.10 %) |
Apr 04 2016 | RSPI | RespireRx Pharmace ... | Margolis Jeff Eliot | VP, Treasurer & Sec ... | Buy | X | 0.00 | 507,374 | 0 | 15,618,816 | 15.1 M to 15.6 M (+3.36 %) |
Apr 04 2016 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | A | 0.02 | 24,000,000 | 544,800 | 24,000,000 | |
Apr 04 2016 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | J | 0.02 | 3,350,319 | 52,600 | 3,350,319 | |
Apr 04 2016 | RSPI | RespireRx Pharmace ... | MANUSO JAMES S J | President and CEO | Option Exercise | A | 0.02 | 26,500,000 | 601,550 | 26,500,000 | |
Apr 04 2016 | RSPI | RespireRx Pharmace ... | MANUSO JAMES S J | President and CEO | Option Exercise | J | 0.02 | 2,630,000 | 52,600 | 2,630,000 | |
Apr 11 2016 | RSPI | RespireRx Pharmace ... | MANUSO JAMES S J | Preident & CEO | Option Exercise | J | 0.02 | 11,887,779 | 178,317 | 11,887,779 | |
Apr 11 2016 | RSPI | RespireRx Pharmace ... | MANUSO JAMES S J | Preident & CEO | Option Exercise | J | 0.00 | 23,775,558 | 0 | 0 | |
Apr 11 2016 | RSPI | RespireRx Pharmace ... | MANUSO JAMES S J | Preident & CEO | Buy | J | 0.00 | 11,887,779 | 0 | 23,775,558 | 11.9 M to 23.8 M (+100.00 %) |
Aug 31 2015 | RSPI | RespireRx Pharmace ... | MANUSO JAMES S J | President and CEO | Option Exercise | P | 0.00 | 23,775,558 | 0 | 23,775,558 | |
Aug 31 2015 | RSPI | RespireRx Pharmace ... | MANUSO JAMES S J | President and CEO | Buy | P | 0.00 | 11,887,779 | 0 | 11,887,779 | 0 to 11.9 M |
Aug 20 2015 | RSPI | RespireRx Pharmace ... | MANUSO JAMES S J | President & CEO | Option Exercise | A | 0.02 | 80,000,000 | 1,576,000 | 80,000,000 | |
Aug 20 2015 | RSPI | RespireRx Pharmace ... | MANUSO JAMES S J | President & CEO | Option Exercise | A | 0.02 | 5,081,300 | 100,102 | 5,081,300 | |
Aug 20 2015 | RSPI | RespireRx Pharmace ... | SAPIRSTEIN JAMES | Director | Option Exercise | A | 0.02 | 3,000,000 | 59,100 | 3,000,000 | |
Aug 20 2015 | RSPI | RespireRx Pharmace ... | MacFarlane Katie | Director | Option Exercise | A | 0.02 | 3,000,000 | 59,100 | 3,000,000 | |
Aug 20 2015 | RSPI | RespireRx Pharmace ... | Purcell Richard David Jr. | SVP - Research & De ... | Option Exercise | A | 0.02 | 3,000,000 | 59,100 | 3,000,000 | |
Aug 20 2015 | RSPI | RespireRx Pharmace ... | WEINGARTEN ROBERT N | VP & Chief Financia ... | Option Exercise | A | 0.02 | 10,000,000 | 197,000 | 10,000,000 | |
Aug 20 2015 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman and ... | Option Exercise | A | 0.02 | 10,000,000 | 197,000 | 10,000,000 | |
Aug 20 2015 | RSPI | RespireRx Pharmace ... | Margolis Jeff Eliot | VP, Treasurer & Sec ... | Option Exercise | A | 0.02 | 10,000,000 | 197,000 | 10,000,000 | |
Jul 06 2015 | RSPI | RespireRx Pharmace ... | SAPIRSTEIN JAMES | Director | Option Exercise | A | 0.03 | 2,000,000 | 50,000 | 2,000,000 | |
Jul 06 2015 | RSPI | RespireRx Pharmace ... | Margolis Jeff Eliot | VP, Treasurer & Sec ... | Option Exercise | A | 0.03 | 15,000,000 | 375,000 | 15,000,000 | |
Jul 06 2015 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Chairman, CEO & Pre ... | Option Exercise | A | 0.03 | 15,000,000 | 375,000 | 15,000,000 | |
Jul 02 2015 | RSPI | RespireRx Pharmace ... | Purcell Richard David Jr. | SVP - Research and ... | Option Exercise | A | 0.03 | 2,000,000 | 50,000 | 2,000,000 | |
Jul 02 2015 | RSPI | RespireRx Pharmace ... | MacFarlane Katie | Director | Option Exercise | A | 0.03 | 2,000,000 | 50,000 | 2,000,000 | |
Jul 02 2015 | RSPI | RespireRx Pharmace ... | WEINGARTEN ROBERT N | VP and CFO | Option Exercise | A | 0.03 | 15,000,000 | 375,000 | 15,000,000 | |
Apr 21 2015 | RSPI | RespireRx Pharmace ... | Purcell Richard David Jr. | SVP - Research and ... | Grant | A | 0.00 | 2,000,000 | 0 | 2,000,000 | 0 to 2 M |
Sep 05 2014 | RSPI | RespireRx Pharmace ... | MacFarlane Katie | Director | Grant | A | 0.00 | 2,000,000 | 0 | 2,000,000 | 0 to 2 M |
Sep 05 2014 | RSPI | RespireRx Pharmace ... | SAPIRSTEIN JAMES | Director | Grant | A | 0.00 | 2,000,000 | 0 | 2,000,000 | 0 to 2 M |
Jul 21 2014 | RSPI | RespireRx Pharmace ... | Margolis Jeff Eliot | VP, Treasurer and S ... | Option Exercise | A | 0.05 | 5,000,000 | 250,000 | 5,000,000 | |
Jul 21 2014 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Chairman, CEO and P ... | Option Exercise | A | 0.05 | 5,000,000 | 250,000 | 5,000,000 | |
Jul 21 2014 | RSPI | RespireRx Pharmace ... | WEINGARTEN ROBERT N | Vice President and ... | Option Exercise | A | 0.05 | 5,000,000 | 250,000 | 5,000,000 | |
Apr 16 2014 | RSPI | RespireRx Pharmace ... | Radin Marc M | Controller | Grant | A | 0.00 | 4,000,000 | 0 | 4,000,000 | 0 to 4 M |
Apr 16 2014 | RSPI | RespireRx Pharmace ... | WEINGARTEN ROBERT N | VP and CFO | Grant | A | 0.00 | 15,000,000 | 0 | 15,000,000 | 0 to 15 M |
Apr 16 2014 | RSPI | RespireRx Pharmace ... | Margolis Jeff Eliot | VP, Treasurer and S ... | Grant | A | 0.00 | 15,000,000 | 0 | 15,000,000 | 0 to 15 M |
Apr 16 2014 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Chairman, CEO and P ... | Grant | A | 0.00 | 15,000,000 | 0 | 15,000,000 | 0 to 15 M |
Mar 20 2014 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Chairman, CEO and P ... | Option Exercise | P | 0.00 | 250 | 0 | 250 | |
Jan 23 2013 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Option Exercise | S | 0.10 | 1,691,367 | 175,056 | 0 | |
Jan 23 2013 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Option Exercise | P | 0.10 | 1,691,367 | 175,056 | 1,691,367 | |
Jan 23 2013 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.04 | 6,765,466 | 270,619 | 0 | 6.8 M to 0 (-100.00 %) |
Jan 23 2013 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Buy | P | 0.04 | 6,765,466 | 270,619 | 16,422,464 | 9.7 M to 16.4 M (+70.06 %) |
Sep 19 2012 | RSPI | RespireRx Pharmace ... | ORIGIN VENTURES II LP | 10% Owner | Buy | J | 0.00 | 24,200,507 | 0 | 24,200,507 | 0 to 24.2 M |
Aug 20 2012 | RSPI | RespireRx Pharmace ... | Carley David W. | Director | Grant | A | 0.00 | 1,899,158 | 0 | 1,899,158 | 0 to 1.9 M |
Aug 14 2012 | RSPI | RespireRx Pharmace ... | STOLL ROGER G PHD | Executive Chairman | Option Exercise | A | 0.06 | 3,083,334 | 185,000 | 3,083,334 | |
Aug 20 2012 | RSPI | RespireRx Pharmace ... | Letendre Peter | Director | Grant | A | 0.00 | 684,031 | 0 | 684,031 | 0 to 684 K |
Aug 14 2012 | RSPI | RespireRx Pharmace ... | COLEMAN JAMES H | Sr. VP, Business De ... | Option Exercise | A | 0.06 | 2,083,334 | 125,000 | 2,083,334 | |
Aug 07 2012 | RSPI | RespireRx Pharmace ... | JOHNSON M ROSS | Director | Option Exercise | A | 0.06 | 368,333 | 22,100 | 398,333 | |
Aug 07 2012 | RSPI | RespireRx Pharmace ... | JOHNSON M ROSS | Director | Option Exercise | A | 0.06 | 30,000 | 1,800 | 30,000 | |
Aug 07 2012 | RSPI | RespireRx Pharmace ... | DRAKE PETER F | Director | Option Exercise | A | 0.06 | 346,667 | 20,800 | 376,667 | |
Aug 07 2012 | RSPI | RespireRx Pharmace ... | DRAKE PETER F | Director | Option Exercise | A | 0.06 | 30,000 | 1,800 | 30,000 | |
Aug 07 2012 | RSPI | RespireRx Pharmace ... | CASAMENTO CHARLES J | Director | Option Exercise | A | 0.06 | 346,667 | 20,800 | 376,667 | |
Aug 07 2012 | RSPI | RespireRx Pharmace ... | CASAMENTO CHARLES J | Director | Option Exercise | A | 0.06 | 30,000 | 1,800 | 30,000 | |
Aug 07 2012 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | A | 0.06 | 216,667 | 13,000 | 246,667 | |
Aug 07 2012 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | A | 0.06 | 30,000 | 1,800 | 30,000 | |
Aug 07 2012 | RSPI | RespireRx Pharmace ... | Benedik John F | Director | Option Exercise | A | 0.06 | 433,333 | 26,000 | 463,333 | |
Aug 07 2012 | RSPI | RespireRx Pharmace ... | Benedik John F | Director | Option Exercise | A | 0.06 | 30,000 | 1,800 | 30,000 | |
Aug 07 2012 | RSPI | RespireRx Pharmace ... | ALLNUTT ROBERT | Director | Option Exercise | A | 0.06 | 303,333 | 18,200 | 333,333 | |
Aug 07 2012 | RSPI | RespireRx Pharmace ... | ALLNUTT ROBERT | Director | Option Exercise | A | 0.06 | 30,000 | 1,800 | 30,000 | |
Jun 27 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Option Exercise | P | 0.06 | 4,000,000 | 224,000 | 4,000,000 | |
Jun 18 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.05 | 30,000 | 1,350 | 9,656,998 | 9.7 M to 9.7 M (-0.31 %) |
Jun 18 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.05 | 18,975 | 949 | 9,686,998 | 9.7 M to 9.7 M (-0.20 %) |
Jun 14 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.05 | 3,245 | 162 | 9,705,973 | 9.7 M to 9.7 M (-0.03 %) |
Jun 14 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.05 | 25,040 | 1,252 | 9,709,218 | 9.7 M to 9.7 M (-0.26 %) |
Jun 14 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.05 | 39,755 | 1,988 | 9,734,258 | 9.8 M to 9.7 M (-0.41 %) |
Jun 12 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.06 | 7,000 | 385 | 9,774,013 | 9.8 M to 9.8 M (-0.07 %) |
Jun 12 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.05 | 50,000 | 2,550 | 9,781,013 | 9.8 M to 9.8 M (-0.51 %) |
Jun 07 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Option Exercise | J | 0.21 | 4,081,633 | 840,816 | 0 | |
Jun 07 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.05 | 40,020 | 2,081 | 9,831,013 | 9.9 M to 9.8 M (-0.41 %) |
Jun 07 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.05 | 75,000 | 3,908 | 9,871,033 | 9.9 M to 9.9 M (-0.75 %) |
Jun 04 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.05 | 17,806 | 951 | 9,946,033 | 10 M to 9.9 M (-0.18 %) |
May 30 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.06 | 5,000 | 285 | 10,113,839 | 10.1 M to 10.1 M (-0.05 %) |
Jun 01 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.05 | 107,606 | 5,585 | 9,963,839 | 10.1 M to 10 M (-1.07 %) |
Jun 01 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.05 | 42,394 | 2,281 | 10,071,445 | 10.1 M to 10.1 M (-0.42 %) |
May 25 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.06 | 1,694 | 97 | 10,118,839 | 10.1 M to 10.1 M (-0.02 %) |
May 25 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.06 | 3,950 | 217 | 10,120,533 | 10.1 M to 10.1 M (-0.04 %) |
May 23 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.06 | 5,000 | 275 | 10,124,483 | 10.1 M to 10.1 M (-0.05 %) |
May 23 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.06 | 5,000 | 275 | 10,129,483 | 10.1 M to 10.1 M (-0.05 %) |
May 21 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.06 | 6,550 | 360 | 10,134,483 | 10.1 M to 10.1 M (-0.06 %) |
May 21 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.06 | 25,000 | 1,500 | 10,141,033 | 10.2 M to 10.1 M (-0.25 %) |
May 16 2012 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.07 | 10,000 | 651 | 10,166,033 | 10.2 M to 10.2 M (-0.10 %) |
Oct 24 2011 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Option Exercise | P | 0.10 | 1,691,367 | 175,056 | 1,691,367 | |
Oct 24 2011 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Buy | P | 0.07 | 6,765,466 | 499,968 | 6,765,466 | 0 to 6.8 M |
May 27 2011 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.12 | 5,000 | 600 | 10,176,033 | 10.2 M to 10.2 M (-0.05 %) |
May 24 2011 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.12 | 10,000 | 1,200 | 10,181,033 | 10.2 M to 10.2 M (-0.10 %) |
May 24 2011 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.12 | 4,446 | 534 | 10,191,033 | 10.2 M to 10.2 M (-0.04 %) |
May 20 2011 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.12 | 50,000 | 6,000 | 10,195,479 | 10.2 M to 10.2 M (-0.49 %) |
May 20 2011 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.12 | 40,100 | 4,812 | 10,245,479 | 10.3 M to 10.2 M (-0.39 %) |
May 18 2011 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.12 | 90,000 | 10,800 | 10,285,579 | 10.4 M to 10.3 M (-0.87 %) |
May 18 2011 | RSPI | RespireRx Pharmace ... | samyang optics co., ltd | 10% Owner | Sell | S | 0.13 | 70,000 | 9,100 | 10,375,579 | 10.4 M to 10.4 M (-0.67 %) |
Mar 03 2011 | RSPI | RespireRx Pharmace ... | ALLNUTT ROBERT | Director | Option Exercise | A | 0.13 | 30,000 | 3,900 | 30,000 | |
Mar 03 2011 | RSPI | RespireRx Pharmace ... | Benedik John F | Director | Option Exercise | A | 0.13 | 30,000 | 3,900 | 30,000 | |
Mar 03 2011 | RSPI | RespireRx Pharmace ... | CASAMENTO CHARLES J | Director | Option Exercise | A | 0.13 | 30,000 | 3,900 | 30,000 | |
Mar 03 2011 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | A | 0.13 | 30,000 | 3,900 | 30,000 | |
Mar 03 2011 | RSPI | RespireRx Pharmace ... | DRAKE PETER F | Director | Option Exercise | A | 0.13 | 30,000 | 3,900 | 30,000 | |
Mar 03 2011 | RSPI | RespireRx Pharmace ... | JOHNSON M ROSS | Director | Option Exercise | A | 0.13 | 30,000 | 3,900 | 30,000 | |
Mar 04 2010 | RSPI | RespireRx Pharmace ... | JOHNSON M ROSS | Director | Option Exercise | A | 0.16 | 30,000 | 4,800 | 30,000 | |
Mar 04 2010 | RSPI | RespireRx Pharmace ... | DRAKE PETER F | Director | Option Exercise | A | 0.16 | 30,000 | 4,800 | 30,000 | |
Mar 04 2010 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | A | 0.16 | 30,000 | 4,800 | 30,000 | |
Mar 04 2010 | RSPI | RespireRx Pharmace ... | CASAMENTO CHARLES J | Director | Option Exercise | A | 0.16 | 30,000 | 4,800 | 30,000 | |
Mar 04 2010 | RSPI | RespireRx Pharmace ... | Benedik John F | Director | Option Exercise | A | 0.16 | 30,000 | 4,800 | 30,000 | |
Mar 04 2010 | RSPI | RespireRx Pharmace ... | ALLNUTT ROBERT | Director | Option Exercise | A | 0.16 | 30,000 | 4,800 | 30,000 | |
Aug 24 2009 | RSPI | RespireRx Pharmace ... | DRAKE PETER F | Director | Option Exercise | A | 0.20 | 30,000 | 6,000 | 30,000 | |
Aug 24 2009 | RSPI | RespireRx Pharmace ... | JOHNSON M ROSS | Director | Option Exercise | A | 0.20 | 30,000 | 6,000 | 30,000 | |
Aug 24 2009 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | A | 0.20 | 30,000 | 6,000 | 30,000 | |
Aug 24 2009 | RSPI | RespireRx Pharmace ... | CASAMENTO CHARLES J | Director | Option Exercise | A | 0.20 | 30,000 | 6,000 | 30,000 | |
Aug 24 2009 | RSPI | RespireRx Pharmace ... | Benedik John F | Director | Option Exercise | A | 0.20 | 30,000 | 6,000 | 30,000 | |
Aug 24 2009 | RSPI | RespireRx Pharmace ... | ALLNUTT ROBERT | Director | Option Exercise | A | 0.20 | 30,000 | 6,000 | 30,000 | |
Aug 24 2009 | RSPI | RespireRx Pharmace ... | Varney Mark A | President and CEO | Option Exercise | A | 0.20 | 588,000 | 117,600 | 588,000 | |
Aug 24 2009 | RSPI | RespireRx Pharmace ... | Tran Pierre V | Chief Medical Offic ... | Option Exercise | A | 0.20 | 50,000 | 10,000 | 50,000 | |
Aug 24 2009 | RSPI | RespireRx Pharmace ... | MESSINGER MARIA S | Chief Financial Off ... | Option Exercise | A | 0.20 | 380,000 | 76,000 | 380,000 | |
Aug 24 2009 | RSPI | RespireRx Pharmace ... | STOLL ROGER G PHD | Executive Chairman | Option Exercise | A | 0.20 | 563,000 | 112,600 | 563,000 | |
Aug 24 2009 | RSPI | RespireRx Pharmace ... | Johnson Steven Andrew | VP, Preclinical Dev ... | Option Exercise | A | 0.20 | 262,000 | 52,400 | 262,000 | |
Aug 24 2009 | RSPI | RespireRx Pharmace ... | COLEMAN JAMES H | Sr. VP, Business De ... | Option Exercise | A | 0.20 | 275,000 | 55,000 | 275,000 | |
Jun 08 2009 | RSPI | RespireRx Pharmace ... | JOHNSON M ROSS | Director | Option Exercise | A | 0.29 | 30,000 | 8,700 | 30,000 | |
Jun 08 2009 | RSPI | RespireRx Pharmace ... | DRAKE PETER F | Director | Option Exercise | A | 0.29 | 30,000 | 8,700 | 30,000 | |
Jun 08 2009 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | A | 0.29 | 30,000 | 8,700 | 30,000 | |
Jun 08 2009 | RSPI | RespireRx Pharmace ... | CASAMENTO CHARLES J | Director | Option Exercise | A | 0.29 | 30,000 | 8,700 | 30,000 | |
Jun 08 2009 | RSPI | RespireRx Pharmace ... | Benedik John F | Director | Option Exercise | A | 0.29 | 30,000 | 8,700 | 30,000 | |
Jun 08 2009 | RSPI | RespireRx Pharmace ... | ALLNUTT ROBERT | Director | Option Exercise | A | 0.29 | 30,000 | 8,700 | 30,000 | |
Jan 13 2009 | RSPI | RespireRx Pharmace ... | Benedik John F | Director | Buy | P | 0.60 | 7,000 | 4,200 | 30,000 | 23 K to 30 K (+30.43 %) |
Jan 13 2009 | RSPI | RespireRx Pharmace ... | Benedik John F | Director | Buy | P | 0.59 | 500 | 295 | 23,000 | 22.5 K to 23 K (+2.22 %) |
Jan 13 2009 | RSPI | RespireRx Pharmace ... | Benedik John F | Director | Buy | P | 0.58 | 10,500 | 6,090 | 22,500 | 12 K to 22.5 K (+87.50 %) |
Dec 16 2008 | RSPI | RespireRx Pharmace ... | Johnson Steven Andrew | VP, Preclinical Dev ... | Option Exercise | M | 0.38 | 8,750 | 3,281 | 0 | |
Dec 16 2008 | RSPI | RespireRx Pharmace ... | Johnson Steven Andrew | VP, Preclinical Dev ... | Buy | M | 0.38 | 8,750 | 3,281 | 30,762 | 22 K to 30.8 K (+39.75 %) |
Dec 10 2008 | RSPI | RespireRx Pharmace ... | ALLNUTT ROBERT | Director | Option Exercise | M | 0.38 | 6,000 | 2,250 | 0 | |
Dec 10 2008 | RSPI | RespireRx Pharmace ... | ALLNUTT ROBERT | Director | Buy | M | 0.38 | 6,000 | 2,250 | 65,500 | 59.5 K to 65.5 K (+10.08 %) |
Dec 04 2008 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | M | 0.38 | 3,000 | 1,125 | 0 | |
Dec 04 2008 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Buy | M | 0.38 | 3,000 | 1,125 | 74,500 | 71.5 K to 74.5 K (+4.20 %) |
Aug 13 2008 | RSPI | RespireRx Pharmace ... | Varney Mark A | President and CEO | Option Exercise | A | 0.97 | 200,000 | 194,000 | 200,000 | |
Jun 02 2008 | RSPI | RespireRx Pharmace ... | Johnson Steven Andrew | VP, Preclinical Dev ... | Grant | A | 0.78 | 11,012 | 8,589 | 22,012 | 11 K to 22 K (+100.11 %) |
Jun 02 2008 | RSPI | RespireRx Pharmace ... | MESSINGER MARIA S | Chief Financial Off ... | Grant | A | 0.78 | 19,064 | 14,870 | 49,064 | 30 K to 49.1 K (+63.55 %) |
Jun 02 2008 | RSPI | RespireRx Pharmace ... | COLEMAN JAMES H | Sr. VP, Business De ... | Grant | A | 0.78 | 7,005 | 5,464 | 207,587 | 200.6 K to 207.6 K (+3.49 %) |
Jun 02 2008 | RSPI | RespireRx Pharmace ... | COLEMAN JAMES H | Sr. VP, Business De ... | Grant | A | 0.74 | 185 | 137 | 200,582 | 200.4 K to 200.6 K (+0.09 %) |
Apr 22 2008 | RSPI | RespireRx Pharmace ... | STOLL ROGER G PHD | Chief Executive Off ... | Buy | P | 0.75 | 20,000 | 15,000 | 100,000 | 80 K to 100 K (+25.00 %) |
Mar 31 2008 | RSPI | RespireRx Pharmace ... | Benedik John F | Director | Buy | P | 0.77 | 12,000 | 9,240 | 12,000 | 0 to 12 K |
Feb 13 2008 | RSPI | RespireRx Pharmace ... | TOLLEFSON GARY D | Director | Option Exercise | A | 0.86 | 30,000 | 25,800 | 30,000 | |
Feb 13 2008 | RSPI | RespireRx Pharmace ... | JOHNSON M ROSS | Director | Option Exercise | A | 0.86 | 30,000 | 25,800 | 30,000 |